UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 161 filers reported holding UNIQURE NV in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $542,436 | -38.3% | 47,333 | +8.5% | 0.00% | -50.0% |
| Q1 2023 | $878,527 | +87752.7% | 43,621 | -1.1% | 0.01% | 0.0% |
| Q4 2022 | $1,000 | -99.9% | 44,090 | +17.7% | 0.01% | +14.3% |
| Q3 2022 | $703,000 | +13.8% | 37,467 | +13.0% | 0.01% | 0.0% |
| Q2 2022 | $618,000 | +10.0% | 33,169 | +6.7% | 0.01% | +16.7% |
| Q1 2022 | $562,000 | -0.5% | 31,076 | +14.1% | 0.01% | 0.0% |
| Q4 2021 | $565,000 | -35.2% | 27,237 | -0.0% | 0.01% | -40.0% |
| Q3 2021 | $872,000 | +158.0% | 27,248 | +216.8% | 0.01% | +66.7% |
| Q3 2019 | $338,000 | -86.3% | 8,600 | -72.7% | 0.01% | -85.7% |
| Q2 2019 | $2,462,000 | +1252.7% | 31,500 | -3.0% | 0.04% | +1300.0% |
| Q4 2016 | $182,000 | – | 32,477 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 939,966 | $21,309,029 | 5.53% |
| Aquilo Capital Management, LLC | 624,854 | $14,165,440 | 5.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 631,500 | $14,297,160 | 4.42% |
| Nantahala Capital Management | 2,700,239 | $61,214,418 | 3.97% |
| Integral Health Asset Management, LLC | 550,000 | $12,468,500 | 2.62% |
| Privium Fund Management B.V. | 301,298 | $6,830,426 | 2.59% |
| 683 Capital Management, LLC | 1,145,000 | $25,957,150 | 2.20% |
| PFM Health Sciences, LP | 2,302,314 | $52,193,458 | 1.87% |
| Nantahala Capital Management | 1,187,700 | $26,925,159 | 1.74% |
| Jetstream Capital LLC | 30,000 | $680,100 | 1.44% |